Indefinite Delivery Contract 36E79725D0026
Award Date
5/23/25
Last Date to Order
5/22/26
Federal Agency
National Acquisition Center
Awardee
Radha Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Mylan Pharmaceuticals Inc. to provide Carbidopa-Levodopa sustained-action (SA) tablets to the Department of Veterans Affairs (VA) National Acquisition Center. The contract has a 5-year period of performance from May 2020 to May 2025, with a ceiling value of $15,670,215.75. Under this IDC, Mylan will annually supply an estimated 50,537 bottles of 100mg Carbidopa-Levodopa SA tablets and 66,850 bottles of...
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) with Avkare LLC, a pharmaceutical and medical supply company based in Pulaski, Tennessee. The contract, awarded by the VA National Acquisition Center, has a ceiling value of $21,739,614.15 and a period of performance from June 21, 2021 to June 20, 2025, with four one-year option periods. The contract is for the delivery of Carbidopa/Levodopa tablets to support the healthcare missions of the VA, Department of Defense...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business, for the supply of Clopidogrel Bisulfate tablets. The $15,979,579.05 contract has a base period of one year and four one-year option periods, with an ultimate completion date of April 14, 2026. The contract aims to provide an uninterrupted supply of Clopidogrel Bisulfate tablets in various bottle...
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite delivery contract to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business and manufacturer of pharmaceutical products. The $13.4 million contract provides for the supply of naproxen tablets in various strengths and package sizes to the VA, Department of Defense, Bureau of Prisons, and Indian Health Service over a 1-year base period with four 1-year option periods. The contract...
This indefinite delivery contract (IDC) was awarded by the National Acquisition Center, a civilian agency of the U.S. government, to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business. The contract, valued at up to $15,026,406.75, provides for the delivery of Bupropion SA 12HR tablets in various bottle sizes and quantities to the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service over a base year period from May 16, 2021...
The Department of Veterans Affairs (VA) has awarded Acorda Therapeutics, Inc., a biotechnology company specializing in neurological therapies, an IDV Federal Supply Schedule contract (36F79723D0194) valued at over $16.3 million. This multiple-award contract covers the procurement of drugs, pharmaceuticals, and hematology-related products through September 2028. Under this IDV, the VA Veterans Integrated Service Network 12 has issued firm fixed-price delivery orders for Acorda's Levodopa 42mg...
The U.S. Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business, for the provision of gabapentin tablets. The $23.5 million IDC has a base year and four one-year option periods, with an ultimate completion date of December 31, 2025. The contract aims to establish a reliable source of supply for high-volume gabapentin tablets in various strengths and...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Radha Pharmaceuticals Inc., a minority-owned and small disadvantaged business, to provide various strengths and bottle configurations of hydralazine tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service. The $11,999,990.25 IDC has a base year period of performance from April 8, 2021 to April 7, 2022, with four one-year option...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to The Harvard Drug Group, L.L.C. doing business as Major Pharmaceuticals & Rugby Laboratories Division. This 1-year base contract, with four 1-year option periods, is valued at $10,056,938.10 and aims to provide an uninterrupted supply of Lurasidone Hydrochloride (HCL) tablets in various dosages to the VA, Department of Defense, Bureau of Prisons, Indian Health...
The federal contract IDV award SPE2D223D0002 is a single-award Indefinite Delivery Contract (IDC) to Radha Pharmaceuticals Inc., a minority-owned small disadvantaged business, for the manufacture and distribution of branded and generic pharmaceutical products. The $23.3 million IDC was awarded on October 6, 2022 by the Defense Logistics Agency (DLA) Troop Support Medical, with an ultimate completion date of October 5, 2027. The IDC utilizes firm-fixed pricing and provides an uninterrupted supply...